New registry to map MDS in asia: no treatment, just data
NCT ID NCT07355478
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that will collect information from about 500 adults in Asia who have been diagnosed with myelodysplastic syndromes (MDS). Researchers will look at patient details like age, sex, medical history, lab results, and treatments received. The goal is to better understand MDS in this region, but no new treatment or medication is given as part of this study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES (MDS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Local Institution - 0001
Taipei, 100229, Taiwan
-
Local Institution - 0003
Singapore, 169608, Singapore
-
Local Institution - 002
Seoul, Seoul Teugbyeolsi, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a liposomal chemo combo outsmart tough leukemias?
- Could a walk a day keep brain fog away after a stem cell transplant?
- New drug cocktail shows promise for rare bone marrow cancer
- Could a common diabetes pill treat anemia in MDS patients?
- Engineered donor cells aim to beat blood cancer without severe side effects
- Major MDS study tracks 2,115 patients to unlock disease secrets